North America Pharmaceutical Excipients Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (Bioresorbable Polymers, and Lipids and Liposome-Based Formulation; Oleochemicals; Sugars; Cellulose; Starches; Petrochemicals; Plant Proteins and Polyols and Cyclodextrins; Inorganic Chemicals; and Others), Clinical Indication (Cancer, Metabolic, Infectious Diseases, Dental, Ophthalmic, Gene Therapies, and Others), Functionality (Coloring Agent and Coating Agent, Sweetener and Flavoring Agents, Suspending and Viscosity Agents, Preservative and Controlled-Release, Antioxidant and Oil, Tablet Filler and Diluents, Binders and Compression Aids and Granulating Agents, and Others), Application (Parenteral, Oral Formulations and Tablets, Capsules, Liquid and Injectables, Physicochemical Excipient-Container Interactions in Prefilled Syringes, Nutraceuticals and OTC, Topical, and Others), and End User (Biopharma Industries, Pharma Industries, Animal Health, and Others)   

No. of Pages: 256    |    Report Code: TIPRE00022815    |    Category: Chemicals and Materials

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
North America Pharmaceutical Excipients Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. North America Pharmaceutical Excipients Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. North America Pharmaceutical Excipients Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Growing demand for drug formulations
  • 5.1.2 Rise in biologic and generic drugs
5.2 Market Opportunities
  • 5.2.1 Expansion in pharmaceutical excipients market
  • 5.2.2 Growth in oral solid dosage forms
5.3 Future Trends
  • 5.3.1 Growth in biopharmaceutical excipients
  • 5.3.2 Increasing demand for customized drug delivery systems
5.4 Impact of Drivers and Restraints

6. North America Pharmaceutical Excipients Market Regional Analysis

6.1 North America Pharmaceutical Excipients Market Overview
6.2 North America Pharmaceutical Excipients Market Revenue 2020-2028 (US$ Million)
6.3 North America Pharmaceutical Excipients Market Forecast Analysis

7. North America Pharmaceutical Excipients Market Analysis – by Type

7.1 Bioresorbable Polymers
  • 7.1.1 Overview
  • 7.1.2 Bioresorbable Polymers: North America Pharmaceutical Excipients Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Lipids and Liposome-Based Formulation
  • 7.2.1 Overview
  • 7.2.2 Lipids and Liposome-Based Formulation: North America Pharmaceutical Excipients Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Oleochemicals
  • 7.3.1 Overview
  • 7.3.2 Oleochemicals: North America Pharmaceutical Excipients Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Sugars
  • 7.4.1 Overview
  • 7.4.2 Sugars: North America Pharmaceutical Excipients Market – Revenue and Forecast to 2031 (US$ Million)
7.5 Cellulose
  • 7.5.1 Overview
  • 7.5.2 Cellulose: North America Pharmaceutical Excipients Market – Revenue and Forecast to 2031 (US$ Million)
7.6 Starches
  • 7.6.1 Overview
  • 7.6.2 Starches: North America Pharmaceutical Excipients Market – Revenue and Forecast to 2031 (US$ Million)
7.7 Petrochemicals
  • 7.7.1 Overview
  • 7.7.2 Petrochemicals: North America Pharmaceutical Excipients Market – Revenue and Forecast to 2031 (US$ Million)
7.8 Plant Proteins and Polyols and Cyclodextrins
  • 7.8.1 Overview
  • 7.8.2 Plant Proteins and Polyols and Cyclodextrins: North America Pharmaceutical Excipients Market – Revenue and Forecast to 2031 (US$ Million)
7.9 Inorganic Chemicals
  • 7.9.1 Overview
  • 7.9.2 Inorganic Chemicals : North America Pharmaceutical Excipients Market – Revenue and Forecast to 2031 (US$ Million)
7.10
  • 7.10.1 Overview
  • 7.10.2 : North America Pharmaceutical Excipients Market – Revenue and Forecast to 2031 (US$ Million)

8. North America Pharmaceutical Excipients Market Analysis – by Clinical Indication

8.1 Cancer
  • 8.1.1 Overview
  • 8.1.2 Cancer: North America Pharmaceutical Excipients Market – Revenue and Forecast to 2028 (US$ Million)
8.2 Metabolic
  • 8.2.1 Overview
  • 8.2.2 Metabolic: North America Pharmaceutical Excipients Market – Revenue and Forecast to 2028 (US$ Million)
8.3 Infectious Diseases
  • 8.3.1 Overview
  • 8.3.2 Infectious Diseases: North America Pharmaceutical Excipients Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Dental
  • 8.4.1 Overview
  • 8.4.2 Dental: North America Pharmaceutical Excipients Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Ophthalmic
  • 8.5.1 Overview
  • 8.5.2 Ophthalmic: North America Pharmaceutical Excipients Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Gene Therapies
  • 8.6.1 Overview
  • 8.6.2 Gene Therapies: North America Pharmaceutical Excipients Market – Revenue and Forecast to 2028 (US$ Million)

9. North America Pharmaceutical Excipients Market Analysis – by Functionality

9.1 Coloring Agent and Coating Agent
  • 9.1.1 Overview
  • 9.1.2 Gene Therapies: North America Pharmaceutical Excipients Market – Revenue and Forecast to 2028 (US$ Million)
9.2 Sweetener and Flavoring Agents
  • 9.2.1 Overview
  • 9.2.2 Gene Therapies: North America Pharmaceutical Excipients Market – Revenue and Forecast to 2028 (US$ Million)
9.3 Suspending and Viscosity Agents
  • 9.3.1 Overview
  • 9.3.2 Gene Therapies: North America Pharmaceutical Excipients Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Preservative and Controlled-Release
  • 9.4.1 Overview
  • 9.4.2 Gene Therapies: North America Pharmaceutical Excipients Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Antioxidant and Oil
  • 9.5.1 Overview
  • 9.5.2 Gene Therapies: North America Pharmaceutical Excipients Market – Revenue and Forecast to 2028 (US$ Million)
9.6 Tablet Filler and Diluents
  • 9.6.1 Overview
  • 9.6.2 Gene Therapies: North America Pharmaceutical Excipients Market – Revenue and Forecast to 2028 (US$ Million)
9.7 Binders and Compression Aids and Granulating Agents
  • 9.7.1 Overview
  • 9.7.2 Gene Therapies: North America Pharmaceutical Excipients Market – Revenue and Forecast to 2028 (US$ Million)

10. North America Pharmaceutical Excipients Market – North America Analysis

10.1 North America
  • 10.1.1 North America Pharmaceutical Excipients Market Breakdown, by Key Country, 2023 and 2028 (%)
  • 10.1.1.1 North America Pharmaceutical Excipients Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 US: North America Pharmaceutical Excipients Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.1.1 US: North America Pharmaceutical Excipients Market Breakdown, by Type
    • 10.1.1.1.2 US: North America Pharmaceutical Excipients Market Breakdown, by Clinical Indication
    • 10.1.1.1.3 US: North America Pharmaceutical Excipients Market Breakdown, by Functionality
  • 10.1.1.2 Canada: North America Pharmaceutical Excipients Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.2.1 Canada: North America Pharmaceutical Excipients Market Breakdown, by Type
    • 10.1.1.2.2 Canada: North America Pharmaceutical Excipients Market Breakdown, by Clinical Indication
    • 10.1.1.2.3 Canada: North America Pharmaceutical Excipients Market Breakdown, by Functionality
  • 10.1.1.3 Mexico : North America Pharmaceutical Excipients Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.3.1 Mexico : North America Pharmaceutical Excipients Market Breakdown, by Type
    • 10.1.1.3.2 Mexico : North America Pharmaceutical Excipients Market Breakdown, by Clinical Indication
    • 10.1.1.3.3 Mexico : North America Pharmaceutical Excipients Market Breakdown, by Functionality

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. North America Pharmaceutical Excipients Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Archer-Daniels-Midland Co
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 AshLand Inc
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Avantor Inc
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 BASF SE
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Evonik Industries AG
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 JRS PHARMA GmbH & Co. KG
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 MEGGLE GmbH & Co KG
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 Roquette Freres SA
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 The Dow Chemical Co
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments
13.10 The Lubrizol Corp
  • 13.10.1 Key Facts
  • 13.10.2 Business Description
  • 13.10.3 Products and Services
  • 13.10.4 Financial Overview
  • 13.10.5 SWOT Analysis
  • 13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - N Market

  1. Archer-Daniels-Midland Co
  2. AshLand Inc
  3. Avantor Inc
  4. BASF SE
  5. Evonik Industries AG
  6. JRS PHARMA GmbH & Co. KG
  7. MEGGLE GmbH & Co KG
  8. Roquette Freres SA
  9. The Dow Chemical Co
  10. The Lubrizol Corp
north-america-pharmaceutical-excipients-market